Delivery Order SPE2DB20D7066-SPE2DB26FC1NT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,256.30 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed price contract. This competitively awarded delivery order, issued on September 4, 2025, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings valued at $1,255.38. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.04 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed price contract. This delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award carries no set-aside designation, indicating it was competitively awarded. Performance...
- The Defense Logistics Agency (DLA) awarded a $12,219.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings, with an ultimate completion date of September 23, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $1,345.05 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 11, 2025, with completion by August 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,331.42 and is scheduled for completion by August 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,496.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of June 9, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, with a ceiling value of $1,165.71. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,354.82 to AmerisourceBergen Drug Corp for Etonogestrel-EE vaginal rings, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.77 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1NTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,345.05 to AmerisourceBergen Drug Corp on November 5, 2025, for etonogestrel-ethinyl estradiol vaginal rings. This is a firm fixed-price delivery order with an ultimate completion date of November 6, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a comprehensive $999.999 billion IDC with DLA Troop Support Medical running through December 2026, which enables delivery of a broad range of pharmaceutical products and medical supplies globally. This specific delivery order for hormonal contraceptive rings supports the company's ongoing role as a primary pharmaceutical supplier to the Defense Health Agency and other federal healthcare customers through flexible contract vehicles designed to meet dynamic medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/5/25 |